Tirzepatide new treatment option for people who are overweight or have obesity: SURMOUNT-1 clinical trial Dr. Kamal Kant Kohli6 Jun 2022 9:45 AM ISTIn the 72-week, phase III SURMOUNT-1 clinical trial the researchers have reported that combination GIP and GLP-1 receptor agonist tirzepatide...
Temporomandibular Disorder-Induced Pain Likely to Worsen in Late Menopause Transition Dr. Kamal Kant Kohli5 Jun 2022 8:00 PM ISTCLEVELAND: The loss of estrogen during the menopause transition can cause a number of physical changes and health concerns-from thinning hair and...
Parents may need support in starting mental health conversations with children, reveals survey Dr. Kamal Kant Kohli3 Jun 2022 9:00 AM IST6COLUMBUS, Ohio: Between the challenges of everyday life and more than two years of the COVID-19 pandemic, kids face more pressure and distraction...
Vitamin D fails to prevent type 2 diabetes in high risk adults: BMJ Dr. Kamal Kant Kohli28 May 2022 10:45 AM ISTDaily vitamin D supplements do not seem to prevent the development of type 2 diabetes in people already at high risk of the condition, finds a trial...
Alarming rise found in esophageal cancer and Barrett's esophagus in middle-aged adults Dr. Kamal Kant Kohli27 May 2022 7:45 PM ISTBethesda, MD: Adults aged 45 to 64 experienced a nearly doubled rate of esophageal cancer and a 50 percent increase in the precancerous condition...
Reducing TV viewing to less than one hour a day could help prevent more than one in ten cases of CAD Dr. Kamal Kant Kohli26 May 2022 10:15 AM ISTWatching too much TV is associated with increased risk of coronary heart disease regardless of an individual's genetic makeup, say a team of...
FDA approves dupilumab as first Treatment for Eosinophilic Esophagitis Dr. Kamal Kant Kohli23 May 2022 9:15 AM ISTDupilumab (Dupixent, Regeneron Pharmaceuticals, Inc.) is first drug in the U.S. specifically indicated for the treatment of eosinophilic...
Once-weekly insulin icodec bests insulin degludec for HbA1c control in diabetics: ONWARDS 2 phase 3a trial Dr. Kamal Kant Kohli13 May 2022 6:00 PM ISTOnce-weekly insulin icodec exhibited superior reduction of HbA1C to the tune of 0.22% compared with insulin degludec in people with type 2 diabetes...
Reduction of CV events by PCSK9 inhibitors and ezetimibe: Clinical practice guideline Dr. Kamal Kant Kohli13 May 2022 9:30 AM ISTAdditional cholesterol lowering drugs should be offered to patients with high levels of 'bad' (LDL) cholesterol (70 mg/dl or higher) who are also at...
Tailoring screening by race and ethnicity may catch diabetes cases earlier, improve health equity Dr. Kamal Kant Kohli12 May 2022 12:30 PM ISTDiabetes is a leading cause of morbidity and mortality, affecting more than 34 million adults in the United States. Current United States Prevention...
Diets high in fiber associated with less antibiotic resistance in gut bacteria Dr. Kamal Kant Kohli11 May 2022 7:15 PM ISTHealthy adults who eat a diverse diet with at least 8-10 grams of soluble fiber a day have fewer antibiotic-resistant microbes in their guts,...
Obesity causes cancer and is major determinant of disability and death, warns new WHO report Dr. Kamal Kant Kohli11 May 2022 12:15 PM ISTAlmost two thirds of adults and 1 in 3 children in the WHO European Region are living with overweight or obesity, and these rates are still growing....
